Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07383909 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jan 31, 2029 → Dec 31, 2029
See other at-risk trials from Fujian Medical University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jan 31, 2029 to Dec 31, 2029 Show 7 more changesShow less
    • Start date: Jan 5, 2026 to Mar 29, 2026
    • Trial sites expanded: 3 → 16 locations
    • Enrollment target: 1296 to 1312
    • Eligibility criteria shortened, about 36 words
    • Secondary endpoints revised (11)
    • Study description expanded, about 16 words
    • Collaborators: 2 to 15
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if a technique called remote ischemic preconditioning (RIPC) helps protect organs during emergency surgery for acute type A aortic dissection (ATAAD). The main questions it aims to answer are: Does RIPC reduce the risk of major complications after surgery, such as heart, brain, or kidney problems? Is RIPC safe to use during emergency ATAAD surgery? Researchers will compare the RIPC group to a control group (who will receive a placebo) to see if RIPC can reduce complications after surgery. Participants will: Receive either RIPC or a sham intervention during their surgery. Be monitored for up to 30 days after surgery for complications. Have follow-up visits at 3 months, 1 year, and then yearly for up to 5 years to track their recovery.
Trial Details
NCT Number NCT07383909
Lead Sponsor Fujian Medical University
Collaborators: Xiamen Cardiovascular Hospital, Xiamen University, The First Affiliated Hospital of Dalian Medical University, Henan Provincial Chest Hospital, RenJi Hospital, Shengjing Hospital, The First Affiliated Hospital of Xiamen University, Qilu Hospital of Shandong University, Xinqiao Hospital, Amry Medical University, First Affiliated Hospital of Harbin Medical University, Yan'an Affiliated Hospital of Kunming Medical University, The Fourth Affiliated Hospital of Harbin Medical University, First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital Xi'an Jiaotong University, The First Affiliated Hospital of Anhui Medical University, Second Xiangya Hospital of Central South University
Conditions
(from sponsor)		 Aortic Dissection Type A
Related terms Reperfusion Injury
Enrollment 1,312 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov